| Prev Close | 120.75 |
| Day Low/High | 120.40 / 122.48 |
| 52 Wk Low/High | 74.51 / 122.48 |
| Avg Volume | 5.23M |
Eli Lilly & Co. (LLY)
122.48
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 1.06B |
| Market Cap | 127.91B |
| P/E Ratio | 38.58 |
| Div & Yield | 2.58 (1.88%) |
Here's How Eli Lilly Stock Can Regain Its Footing
Watch these key price levels on LLY.
Intermediate Trade: Eli Lilly
Consider this LLY out of the money, bullishly biased vertical call spread expiring in April.
Jim Cramer: I Wish Some Stocks Would Not Keep Rallying
Facebook is making itself a tough own ahead of the quarterly results.
Big Pharma and the Sellers of Its Products Now Have a Problem
Who, out there in the health care sector, is safe?
A Rally in Eli Lilly Could Heal Traders, Investors
Prices have improved the past eight weeks and now I want to turn up the volume.
Intermediate Trade: Eli Lilly
This is a bullish trade, but it's best to use limit orders.
Some Afternoon Observations
* Thus far, my expectation of an "inside day" has been accurate. SPDR S&P 500 ETF has traded in a fifty cent range most of the day. * Bonds are at the day's highs. +$0.88. Yield on the 10-year U.S. note is down by 3.5 basis points to 2.32% (where y...
Notable Movements
In terms of sector price movement today: * FANGs continue to extend recent gains. * Retail has picked up a bid late in the day. Walmart Dillard's and Foot Locker are upside features. * Big Pharma stronger -- led by Merck ,Bristol-Myers Squibb , Lil...
Closing Bell: LIVE MARKETS BLOG
The Dow had a record high close.
Cramer: How We Got Into This Rotation
Everything's set up to compound it, and that's just what's happening.
Eli Lilly Had a Good Quarter but Investors Don't Want Health Stocks: Jim Cramer
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer said Eli Lilly LLY had a good quarter but the stock is getting hit by a rotation, as opposed to its specific performance.
Caterpillar, McDonald's and 3M Earnings Fuel Stock Rebound
Strong earnings from Dow components Caterpillar, McDonald's and 3M were on track to push the blue-chip index higher after a 0.23% decline on Monday.
Eli LIlly Beats, Sears Cuts Whirlpool: Tuesday's Top Stories
Top stories today: Eli Lilly is raising its projections for the entire year since its newer drugs are doing well, Sears stops selling Whirlpool appliances in their stores and President Trump meets with lawmakers to discuss tax reform.
How to Manage GE Risk and the Netflix-Disney Fight: Market Recon
Entering GE too early has its costs, but there are ways to mitigate them.
Closing Bell: LIVE MARKETS BLOG
The Dow closed at a new record Tuesday.
Lilly Is Testing Old Resistance
Stock is neither bullish nor bearish right now.
Watch: Jim Cramer Reveals His Outlook for Eli Lilly and Bristol Myers
Eli Lilly is a holding of Jim Cramer's charitable trust, Action Alerts PLUS.
Cramer: Is There a Human Element to This Rally?
It could be all machine-to-machine and not much more than that.
Eli Lilly Still Looking for Lower Prices
The charts don't look positive for drug company Eli Lilly.
Cramer: Got the Apple-FANG Blues? Look for a Rotation
There's one going on now.
Is Lilly Headed for the Valley?
The path of least resistance for LLY is lower.
Some Weak Names Today
An old trading dictim is that you might consider selling or shorting stocks that are in the red when the market is broadly in the green (and vice versa). Some conspicuous stocks that are weak today include Comcast , Gilead , Sprint , and Lilly .
Stocks Seesaw as U.S. Prepares for Hurricane Irma and Recovers From Harvey
Stocks struggled for direction through the morning session as Hurricane Irma approached the U.S. mainland even as Texas and Louisiana continued recovery efforts after Hurricane Harvey.
Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly
Merck vs. Eli Lilly.
Here's What Up (and Down)
After 90 minutes of trading here are some market features: * Bonds are getting schmeissed. The 10-year U.S. note yield is close to 2.32% and the long bond is knocking on the door of 3.00%. A possible equity market headwind. * Retail still has a ni...
Biotech Sees Sharp Reversal
Biotech, as represented by iShares Nasdaq Biotechnology Index Fund , universally beloved by technicians and "talking heads" has just suffered an abrupt intraday turnaround. There may be a lesson here -- that charts often tell us where stocks have be...
Wall Street Preview: Tech Stocks and Oil in Focus
Investors digest earnings from Alphabet Inc and Eli Lilly & Co.
